All Stories

  1. Increased right atrial appendage apoptosis is associated with differential regulation of candidate MicroRNAs 1 and 133A in patients who developed atrial fibrillation after cardiac surgery
  2. Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results
  3. Anti-apoptotic Effect of β1 Blockers in Ascending Thoracic Aortic Smooth Muscle Cells
  4. Diuretic dosing in heart failure: more data are needed
  5. Pericardial masses and congenital abnormalities
  6. Transplantation in patients with iron overload: is there a place for magnetic resonance imaging?
  7. Takotsubo syndrome – adding pieces to a complex puzzle
  8. The MOGE(S) classification for cardiomyopathies: current status and future outlook
  9. Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
  10. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy
  11. Coronary artery ectasia and inflammatory cytokines: Link with a predominant Th-2 immune response?
  12. Alcohol septal ablation for recurrent left ventricular outflow tract obstruction after combined myectomy and mitral valve repair in hypertrophic cardiomyopathy
  13. Hypertrophic cardiomyopathy
  14. Echokontrastmittelgesteuerte Alkoholablation bei hypertropher obstruktiver Kardiomyopathie mit neuem Echokontrastmittel
  15. Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation
  16. Optimal branch selection in alcohol septal ablation
  17. A Decade of Percutaneous Septal Ablation in Hypertrophic Cardiomyopathy
  18. Aortic distensibility associates with increased ascending thoracic aorta diameter and left ventricular diastolic dysfunction in patients with coronary artery ectasia
  19. Hypertrophic cardiomyopathy as a cause of sudden death
  20. Long-Term Nonoutflow Septal Versus Apical Right Ventricular Pacing: Relation to Left Ventricular Dyssynchrony
  21. Mobile pulmonary valve thrombus as a cause of chronic thromboembolic pulmonary hypertension
  22. Molecular diagnosis of the viral component in cardiomyopathies: pathophysiological, clinical and therapeutic implications
  23. Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome
  24. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
  25. Prosthetic Valve Endocarditis due to Acinetobacter spp: A Rare Case and Literature Review
  26. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Collateral vessel communication between septal branches
  27. Left Ventricular Noncompaction of the Ventricular Myocardium: Ever a Challenging Diagnosis
  28. Clinical features of hypertrophic cardiomyopathy caused by an Arg278Cys missense mutation in the cardiac troponin T gene
  29. Ablación septal en la miocardiopatía hipertrófica: situación actual
  30. Subclinical skeletal muscle abnormalities in patients with hypertrophic cardiomyopathy and their relation to clinical characteristics
  31. Management of Hypertrophic Cardiomyopathy in Children
  32. Ablación septal en la miocardiopatía hipertrófica: situación actual
  33. Clinical markers for the identification of gene carriers in naxos disease families
  34. Inherited cardiovascular diseases: identification of silent/subclinical forms by screening target groups
  35. Isolated Left Ventricular Noncompaction: An Unclassified Cardiomyopathy with Severe Prognosis in Adults
  36. Prevalence of carrier status in relatives of naxos disease patients Nikos Protonotarios, Adalena Tsatsopoulou, Aris Anastasakis, Antigone Miliou, Elias Sevdalis, Angelos Rigopoulos, Artemisia Theopistou, Godfrina McCoy, Christodoulos Stefanadis, Pavlos...
  37. Electromyographic evidence of subclinical myopathy in hypertrophic cardiomyopathy
  38. Usefulness of Noninvasive Detection of Left Ventricular Diastolic Abnormalities During Isometric Stress in Hypertrophic Cardiomyopathy and in Athletes
  39. Alcohol Septal Ablation